Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Riddell

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1996
Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virusC Yee, M J Gilbert, S R Riddell, et al.
Journal of Medical Virology|May 1, 1994
Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytesE McLaughlin-Taylor, H Pande, S J Forman, et al.
Human Gene Therapy|August 31, 1999
Expression of chimeric granulocyte-macrophage colony-stimulating factor/interleukin 2 receptors in human cytotoxic T lymphocyte clones results in granulocyte-macrophage colony-stimulating factor-dependent growthL S Evans, P R Witte, A L Feldhaus, et al.
Tissue Antigens|July 24, 2002
Feasibility of using genetic linkage analysis to identify the genes encoding T cell-defined minor histocompatibility antigensE H Warren, B E Otterud, R W Linterman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2000
The human UTY gene encodes a novel HLA-B8-restricted H-Y antigenE H Warren, M A Gavin, E Simpson, et al.
Cancer Journal (Sudbury, Mass.)|June 30, 2000
Immunotherapy of human viral and malignant diseases with genetically modified T-cell clonesS R Riddell, E H Warren, M A Gavin, et al.
Cytotherapy|December 11, 2002
T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinomaE H Warren, S S Tykodi, M Murata, et al.
Nature Medicine|September 2, 1999
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cellsR Tomazin, J Boname, N R Hegde, et al.
Science (New York, N.Y.)|August 29, 1997
A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexesB Ortmann, J Copeman, P J Lehner, et al.
The Journal of Experimental Medicine|December 6, 2000
Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligoC Yee, J A Thompson, P Roche, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1996
Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virusC Yee, M J Gilbert, S R Riddell, et al.
Journal of Medical Virology|May 1, 1994
Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytesE McLaughlin-Taylor, H Pande, S J Forman, et al.
Human Gene Therapy|August 31, 1999
Expression of chimeric granulocyte-macrophage colony-stimulating factor/interleukin 2 receptors in human cytotoxic T lymphocyte clones results in granulocyte-macrophage colony-stimulating factor-dependent growthL S Evans, P R Witte, A L Feldhaus, et al.
Tissue Antigens|July 24, 2002
Feasibility of using genetic linkage analysis to identify the genes encoding T cell-defined minor histocompatibility antigensE H Warren, B E Otterud, R W Linterman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2000
The human UTY gene encodes a novel HLA-B8-restricted H-Y antigenE H Warren, M A Gavin, E Simpson, et al.
Cancer Journal (Sudbury, Mass.)|June 30, 2000
Immunotherapy of human viral and malignant diseases with genetically modified T-cell clonesS R Riddell, E H Warren, M A Gavin, et al.
Cytotherapy|December 11, 2002
T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinomaE H Warren, S S Tykodi, M Murata, et al.
Nature Medicine|September 2, 1999
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cellsR Tomazin, J Boname, N R Hegde, et al.
Science (New York, N.Y.)|August 29, 1997
A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexesB Ortmann, J Copeman, P J Lehner, et al.
The Journal of Experimental Medicine|December 6, 2000
Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligoC Yee, J A Thompson, P Roche, et al.
Pageof 8